Cargando…
Variation in clinical and patient‐reported outcomes among complex heart failure with preserved ejection fraction phenotypes
AIMS: The aim of this study is to use six previously described heart failure with preserved ejection fraction (HFpEF) phenotypes to describe differences in (i) the biological response to spironolactone, (ii) clinical endpoints, and (iii) patient‐reported health status by HFpEF phenotype and treatmen...
Autores principales: | Flint, Kelsey M., Shah, Sanjiv J., Lewis, Eldrin F., Kao, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261552/ https://www.ncbi.nlm.nih.gov/pubmed/32160420 http://dx.doi.org/10.1002/ehf2.12660 |
Ejemplares similares
-
The future of heart failure with preserved ejection fraction: Deep phenotyping for targeted therapeutics
por: Heinzel, Frank R., et al.
Publicado: (2022) -
Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018) -
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016) -
Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction
por: Guazzi, Marco, et al.
Publicado: (2021) -
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)